Related Experiment Video
Updated: Jan 27, 2026

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
Published on: February 16, 2015
Pediatric Survivorship: Considerations Following CAR T-Cell Therapy
Colleen Callahan1, Amy Barry1, Stephanie Fooks-Parker1
1Children's Hospital of Philadelphia.
Background:
This article presents an overview of pediatric relapsed and refractory acute lymphoblastic leukemia (ALL) and chimeric antigen receptor (CAR) T-cell therapy in pediatric patients.
Objectives:
Acute and chronic post-CAR T-cell effects and considerations are discussed, along with survivorship considerations.
Methods:
A case study illustrates the identification and management of physiologic and psychosocial sequelae.
Findings:
B-cell aplasia, hypogammaglobulinemia, infections, and cumulative effects of CAR T-cell therapy and other treatments are a concern in the pediatric population. Unique to pediatric and young adult survivors of childbearing potential are implications for post-treatment fertility. Financial toxicities and psychosocial needs require a family-centered approach to interventions that address the impact of CAR T-cell therapy not only on the patient, but also on caregivers and siblings.
Related Concept Videos
Design Consideration
The factor of safety is another key...
Tensile Strength Considerations of Concrete
The dimensions and shape of a concrete specimen...
Transmission Line Design Considerations
Gene Therapy
Special considerations while measuring pulse
Energy Considerations in Open Channel Flow

